戴维医疗(300314.SZ):产品低压吸引器完成了延续注册
格隆汇 1 月 14日丨戴维医疗(300314.SZ)公布,公司于近日取得由浙江省药品监督管理局颁发的1项《医疗器械注册证》,公司产品低压吸引器完成了延续注册,同时因相关注册法规的要求,完成了对该产品注册证编号、产品名称的变更,具体如下:

上述《医疗器械注册证》的延续注册及变更,有利于进一步提升并延续公司在婴儿保育设备领域的持续竞争力,对公司未来经营将产生积极影响。上述产品的实际销售情况取决于未来市场推广效果,公司目前尚无法预测其对公司未来业绩的影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.